These findings are consistent with the experimental observation of Nadadur et al. 21 in atrial cells, in which the physiologic effects of reduced TBX5 dose, including decreased expression of critical AF genes, atrial rhythm instability, cellular AF abnormalities and AF susceptibility, were all rescued by reduced PITX2 dose. The gene discussed is TBX5; the disease is atrial fibrillation.